Trials / Unknown
UnknownNCT05740969
Gene and Protein Expression Profiles After Treatment of Actinic Keratoses
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 48 (estimated)
- Sponsor
- Ismail Gögenur · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary aim of this study is to investigate the effect of 5-fluorouracil, imiquimod, and melatonin for actinic keratosis on immunological gene, and protein expressions profiles. Secondarily, the aim is to assess the effect of the treatment on the histopathology of actinic keratoses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 5Fluorouracil | Cream |
| DRUG | Imiquimod | Cream |
| DRUG | Melatonin | Cream |
Timeline
- Start date
- 2023-02-01
- Primary completion
- 2024-02-01
- Completion
- 2024-12-31
- First posted
- 2023-02-23
- Last updated
- 2023-02-23
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT05740969. Inclusion in this directory is not an endorsement.